Efficacy of a 14-Day Bismuth-Containing Quadruple Therapy Guided by Drug Susceptibility Testing in Patients with Extremely Refractory Helicobacter Pylori Infection: an Exploratory Study

NCT06731023 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

HELICOBACTER PYLORI INFECTIONS

Interventions

DRUG: Bismuth
DRUG: Vonoprazan
DRUG: Amoxicillin
DRUG: Rifabutin
DRUG: Metronidazole
DRUG: Other antibiotics

Sponsor

Xiuli Zuo